Search results for "Coronavirus"


 
Results 61 - 70 of about 271 for "Coronavirus".
Sort by: Relevance | Newest | Oldest

Breakthrough infections, cardiovascular effects of COVID-19, pandemic mental health

Two new studies reported on infections in fully vaccinated people, while another looked at the rate of myocardial infarction and stroke in patients with COVID-19. A survey found depression and anxiety to be common during the pandemic, and the push for mandatory vaccination of health care workers continued.
https://acphospitalist.acponline.org/weekly/archives/2021/08/04/1.htm
4 Aug 2021

Pandemic lessons, VTE prediction, and COVID-19 effects on other inpatients

One hospital reduced unnecessary labs during the pandemic, while another collected nine lessons to improve health care. Other recent studies looked at venous thromboembolism (VTE) in COVID-19 inpatients and mortality rates among patients hospitalized for other conditions during last year's surges.
https://acphospitalist.acponline.org/weekly/archives/2021/07/28/1.htm
28 Jul 2021

Mixed results for remdesivir, negative results for canakinumab, and new vaccine information

Remdesivir appeared to be of benefit in one study but was associated with increased length of stay and no improvement in survival in another, an industry-funded trial found no benefit for canakinumab in severe COVID-19, and the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine.
https://acphospitalist.acponline.org/weekly/archives/2021/07/21/1.htm
21 Jul 2021

Good news on IL-6 inhibitors for COVID-19, bad news on other drugs, effects of surge

The NIH updated its guidelines; recent research looked at interleukin-6 (IL-6) inhibitors, ivermectin, remdesivir, and hydroxychloroquine in COVID-19; and one study estimated that 23.2% of inpatient COVID-19 deaths last spring and summer could relate to hospital strain.
https://acphospitalist.acponline.org/weekly/archives/2021/07/14/1.htm
14 Jul 2021

New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports

The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://acphospitalist.acponline.org/weekly/archives/2021/06/30/1.htm
30 Jun 2021

Latest COVID-19 research focuses on another drug, racial disparities, early infections

A Brazilian trial found benefit from tofacitinib in hospitalized patients, while a study of Medicare patients showed racial disparities might stem from differences between hospitals.
https://acphospitalist.acponline.org/weekly/archives/2021/06/23/1.htm
23 Jun 2021

COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia

Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/1.htm
16 Jun 2021

Studies show pandemic's effects on emergency care, NIH recommends baricitinib for some

Multiple studies found changed patterns in cardiac emergencies and care associated with the pandemic, and the NIH's COVID-19 guideline panel recommended baricitinib for patients on high-flow oxygen or noninvasive ventilation.
https://acphospitalist.acponline.org/weekly/archives/2021/06/09/1.htm
9 Jun 2021

New research adds to data on symptoms after COVID-19, vaccines' effects

Several COVID-19 studies looked at persistent symptoms, while new vaccine research found limited antibody responses in some patients and advised on tests for clotting complications. Other studies quantified the target population for tocilizumab treatment and gender differences in infections.
https://acphospitalist.acponline.org/weekly/archives/2021/05/26/1.htm
26 May 2021

Studies assess responses, reactions to vaccines; long-term effects of COVID-19 infection

Recent COVID-19 vaccine studies showed good response in pregnant women, as well as possible localized rashes from the Moderna vaccine. Analyses of ICU patients and those treated at a post-COVID-19 clinic highlighted the long-term effects of the virus, and a study found that dialysis patients maintained antibodies six months after COVID-19 infection.
https://acphospitalist.acponline.org/weekly/archives/2021/05/19/2.htm
19 May 2021

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next